MedTrace Logo

DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)

NCT01662518 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-02-01

No results posted yet for this study

Summary

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone (DDS-25) for the treatment of macular edema associated with retinal vein occlusion.

Conditions

  • Macular Edema
  • Retinal Vein Occlusion

Interventions

DEVICE

Dexamethasone drug delivery system (DDS-25)

350 mg Dexamethasone posterior segment drug delivery system (DDS-25) injection into the vitreous cavity at baseline

Sponsors & Collaborators

  • University of Sao Paulo

    collaborator OTHER

  • Centro de Pesquisa Rubens Siqueira

    lead OTHER

Principal Investigators

  • Rubens C Siqueira, MD,PhD · Centro de Pesquisa Rubens Siqueira

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2016-01-31
Completion
2016-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01662518 on ClinicalTrials.gov